Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial
Clinical Advances in Periodontics · 2024
DOI: 10.1002/cap.10262 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Advances in Periodontics, 2024. Verfasst von Subash Chandra Raj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, S.C.B Dental College and Hospital, Cuttack, Odisha, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Alveolar Bone Loss, Gels, Zoledronic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
This 6‐month randomized split‐mouth and placebo‐controlled clinical trial aimed to evaluate the clinical and radiographic efficacy of adjunctive use of 0.05% zoledronate (ZLN) gel as local drug delivery to scaling and root planing (SRP) in stage III, grade B periodontitis patients with and without controlled type‐2 diabetes mellitus (DM).
Methods
A total of 120 infrabony sites were divided into two groups: Group‐1 (non‐diabetic periodontitis) and Group‐2 (periodontitis + DM). A total of 60 sites in each group were randomized to receive treatment with SRP + placebo gel (control) or SRP + 0.05% ZLN gel (test). Plaque index (PI), modified sulcus bleeding index (mSBI), pocket probing depth (PPD), and relative attachment levels (RAL) were assessed at baseline, 3 and 6 months, and digital intraoral periapical and cone‐beam computed tomography imaging were used to measure the linear and percentage reduction of intrabony defect depth (DD, DDR%) after 6 months.
Results
Group‐1 showed significant reduction in PI (0.56 ± 0.15 and 0.52 ± 0.19 from 0.67 ± 0.17), mSBI (0.7 ± 0.60 and 0.47 ± 0.57 from 0.9 ± 0.48), PPD (4.6 ± 0.85 and 3.43 ± 0.63 from 6.5 ± 1.04) and gain in RAL (7.03 ± 0.85 and 5.93 ± 0.69 from 8.9 ± 1.09) in the ZLN‐treated sites than the placebo sites and also from Group‐2 sites after 3 and 6 months, respectively. A significant reduction in DD of 28.79% in Group‐1 and 22.20% in Group‐2 at ZLN sites was seen compared to placebo sites of both groups.
Conclusion
ZLN gel applied subgingivally in infrabony pockets resulted in significant clinical improvements evident by probing depth reduction and gain in attachment levels along with radiographic evidence of more bone fill seen in non‐diabetic patients compared to diabetic periodontitis patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics, S.C.B Dental College and Hospital, Cuttack, Odisha, India.
- School of Pharmaceutical Sciences, Siksha-O-Anusandhan, Deemed to be University, Bhubaneswar, Odisha, India.
ORCID-Profile: Subash Chandra Raj, Asit Kumar Mishra, Devapratim Mohanty, Neelima Katti, Snigdha Pattnaik, Laxmikanta Patra
Zitieren
APA
Raj, S. C., Mishra, A. K., Mohanty, D., Katti, N., Pattnaik, S., Patra, L., & Pattanaik, A. (2024). Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial. Clinical Advances in Periodontics. https://doi.org/10.1002/cap.10262
Vancouver
Raj SC, Mishra AK, Mohanty D, Katti N, Pattnaik S, Patra L, et al. Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial. Clinical Advances in Periodontics. 2024. doi:10.1002/cap.10262
BibTeX
@article{Raj2024,
author = {Raj, Subash Chandra and Mishra, Asit Kumar and Mohanty, Devapratim and Katti, Neelima and Pattnaik, Snigdha and Patra, Laxmikanta and Pattanaik, Abinash},
title = {Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type‐2 diabetes mellitus—A randomized split‐mouth clinical trial},
journal = {Clinical Advances in Periodontics},
year = {2024},
doi = {10.1002/cap.10262}
}
EUVIMED